Saturday 29 June 2013
Dutch drugmaker Prosensa jumps 54 percent in U.S. stock market debut
(Reuters) - Dutch drugmaker Prosensa Holding received a buoyant welcome in its market debut on the Nasdaq, a day after U.S. health regulators granted a "breakthrough status" to its drug to treat a rare disease. Prosensa's shares open...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.